TNFα, PDGF, and TGFβ synergistically induce synovial lining hyperplasia via inducible PI3Kδ
Hideyuki Shibuya1, Hiroyuki Yoshitomi, Koichi Murata
1Department of Orthopaedic Surgery, Kyoto University Graduate School of Medicine , Kyoto , Japan.
Objectives:
To determine the mechanism underlying hypertrophic synovium in rheumatoid arthritis (RA).
Methods:
We examined micromass cultures of fibroblast-like synoviocytes (FLSs) stimulated with tumor necrosis factor α (TNFα), platelet-derived growth factor (PDGF), and/or transforming growth factor β (TGFβ). The hypertrophic architecture of the micromasses, expression of phosphoinositide 3 kinase (PI3K) isoforms, and persistent activation of PI3K-Akt pathways were investigated. FLSs transfected with siRNA were also examined in the micromass cultures.
Results:
The combination of TNFα, PDGF, and TGFβ (TPT condition) induced obvious hypertrophic architecture of the intimal lining layer in FLSs in micromass cultures, and was accompanied by upregulated expression of matrix metalloproteinase-3 (MMP3), Cadherin-11, and PI3Kδ. In monolayer FLSs, the TPT condition enhanced the expression of PI3Kδ and persistent activation of the PI3K-Akt pathway. Knockdown of PI3Kδ significantly inhibited the formation of the hypertrophic synovial lining in the TPT condition.
Conclusions:
These results collectively indicate that inducible PI3Kδ plays a crucial role in persistent activation of PI3K-Akt in FLSs, and in the formation of a hypertrophic synovial lining. PI3Kδ may be an alternative treatment target for the regulation of proliferative synovium in RA.
Insights
Inducible phosphoinositide 3 kinase delta (PI3Kδ) drives persistent PI3K-Akt pathway activation in fibroblast-like synoviocytes (FLSs). This leads to the formation of a hypertrophic synovial lining, a key feature of rheumatoid arthritis (RA).
Area of Science:
- Rheumatology
- Cell Biology
- Molecular Biology
Background:
- Rheumatoid arthritis (RA) is characterized by synovial inflammation and hyperplasia.
- The hypertrophic synovium contributes to joint destruction in RA.
- Understanding the molecular mechanisms of synovial hypertrophy is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms driving synovial hypertrophy in rheumatoid arthritis (RA).
- To investigate the role of phosphoinositide 3 kinase (PI3K) isoforms in fibroblast-like synoviocyte (FLS) proliferation and synovial lining formation.
Main Methods:
- Micromass cultures of FLSs were stimulated with tumor necrosis factor α (TNFα), platelet-derived growth factor (PDGF), and transforming growth factor β (TGFβ).
- Expression of PI3K isoforms and activation of the PI3K-Akt pathway were analyzed.
- Small interfering RNA (siRNA) was used to knockdown PI3Kδ in FLSs.
Main Results:
- Combined stimulation (TPT condition) induced hypertrophic architecture in FLS micromass cultures.
- TPT condition upregulated matrix metalloproteinase-3 (MMP3), Cadherin-11, and PI3Kδ expression.
- Knockdown of PI3Kδ significantly inhibited hypertrophic synovial lining formation.
Conclusions:
- Inducible PI3Kδ is critical for persistent PI3K-Akt activation and hypertrophic synovial lining formation in RA.
- PI3Kδ represents a potential therapeutic target for managing proliferative synovitis in RA.
Related Concept Videos
TGF - β Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
NF-kB-dependent Signaling Pathway
Regulation of Angiogenesis and Blood Supply


